Vertex Pharmaceuticals Incorporated (FRA:VX1)
333.45
-2.30 (-0.69%)
At close: Aug 15, 2025, 10:00 PM CET
Vertex Pharmaceuticals Market Cap
Vertex Pharmaceuticals has a market cap or net worth of €86.00 billion as of August 15, 2025. Its market cap has decreased by -28.37% in one year.
Market Cap
86.00B
Enterprise Value
77.04B
Revenue
9.72B
Ranking
n/a
PE Ratio
27.77
Stock Price
€333.45
Market Cap Chart
Since July 24, 1991, Vertex Pharmaceuticals's market cap has increased from 73.88M to 86.00B, an increase of 116,305.58%. That is a compound annual growth rate of 23.02%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
SAP SE | 279.10B |
Siemens Aktiengesellschaft | 181.30B |
Deutsche Telekom AG | 149.07B |
Allianz SE | 143.65B |
Siemens Energy AG | 77.30B |
Rheinmetall AG | 75.19B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 71.88B |
Deutsche Bank Aktiengesellschaft | 60.38B |